PRP pharmacopuncture for chronic neck pain from upper trapezius myofascial syndrome
Official title: The Effectiveness of Pharmacopuncture With Platelet-Rich Plasma (PRP) as a Treatment for Chronic Neck Pain in Cervical Myofascial Syndrome Related to the Upper Trapezius Muscle
Run by Universitas Indonesia · NCT07119255 · Data updated 2026-11-12
This trial will try a single Platelet‑Rich Plasma (PRP) pharmacopuncture injection to see if it reduces chronic neck pain and improves function in adults with upper trapezius myofascial pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 59 Years |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | Universitas Indonesia Academic / other |
| Locations | 1 site (Jakarta) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | August 2026 |
| Study ends | August 2026 |
| Registry record updated | April 16, 2026 |
| Trial ID | NCT07119255 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–59 with chronic (>3 months) neck pain localized to the upper trapezius, a VAS activity score between 30 and 70 mm, and physical exam findings consistent with myofascial trigger points who meet blood count and health criteria are ideal candidates.
✕Probably not a fit
People with fibromyalgia, structural cervical spine abnormalities (other than degenerative changes), low hemoglobin or platelet counts, fever, or other excluded systemic conditions are unlikely to benefit or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, placebo‑controlled interventional trial comparing a single PRP pharmacopuncture treatment to normal saline pharmacopuncture in adults with chronic neck pain from upper trapezius myofascial syndrome. Sixty participants aged 18–59 with chronic neck pain (>3 months) and a VAS activity score of 30–70 mm will be enrolled and randomly assigned to PRP or placebo. Outcomes include pain, function, quality of life, and adverse events measured at 2, 4, and 8 weeks after the intervention. The trial focuses on localized trigger‑point treatment and uses standardized follow-up assessments to detect short‑term benefits and safety signals.
Why it matters
Potential benefit: If successful, this approach could offer a single‑session, localized treatment that reduces chronic neck pain and improves function and quality of life for people with upper trapezius myofascial pain.
How similar studies have gone: Small trials and case series of PRP or trigger‑point injections have reported some pain relief for myofascial conditions, but the evidence is limited and not yet conclusive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged 18 to 59 years. * Experiencing neck pain for more than 3 months (chronic). * Neck pain classified as Grade I to III according to the Neck Pain Task Force classification. * Presence of referred pain pattern on physical examination consistent with the distribution of the upper trapezius muscle. * Visual Analogue Scale (VAS) score between 30 and 70 mm (out of 100 mm) during activity (e.g., daily activities or light exercise). * Willing to participate in the study until completion and has signed the informed consent form. Exclusion Criteria: * Hemoglobin level \<13 g/dL for males or \<12 g/dL for females. * Platelet count \<150,000/μL. * Presence of fever (≥37.5°C). * Diagnosis of fibromyalgia. * Structural abnormalities of the cervical spine other than degenerative changes, such as fractures, cervical spine injuries, space-occupying lesions (SOL), infections, neoplasms, or systemic diseases confirmed by radiographic imaging. * History of cervical spine surgery. * Presence of tumors, wounds, or skin infections at the needle insertion site. * Diagnosed with blood disorders or currently taking anticoagulant or antiplatelet medications. * History of hypersensitivity reactions to acupuncture (e.g., metal allergy, severe atopy, keloids, or other skin hypersensitivities). * Uncontrolled cardiovascular disease or diabetes mellitus. * History of pharmacopuncture therapy to the upper trapezius muscle within the past 6 months. * Use of anti-inflammatory medication within the past 2 weeks. * Currently pregnant or breastfeeding.
Where it's running
-
Fakultas Kedokteran Universitas Indonesia
Jakarta, Indonesia Recruiting
Study contacts
- Principal investigator: Kepk Fkui-Rscm — The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM
- Study coordinator: Irma Nareswari, MD
- Email: i.nareswarifkuirscm@yahoo.com
- Phone: +6281267793888
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Upper extremity function in neck pain: comparing people with chronic neck pain to healthy individuals
We will test how chronic non-specific neck pain affects upper body function and quality of life by comparing people with neck pain to healthy adults.
-
Kinesiology Taping vs Self-Mobilization for Neck Pain from Prolonged Device Use
This study tests whether applying kinesiology tape or doing self-mobilization helps adults with neck pain who spend many hours on electronic devices.
-
Biofeedback and Mulligan neck therapy for mechanical neck pain in women
This study tests whether adding biofeedback-guided deep cervical flexor training to Mulligan mobilization and standard neck exercises helps reduce pain and improve movement in women aged 18–45 with mechanical neck pain.
-
Gelified radiopaque ethanol for cervical disc herniation in routine care
This observational study looks at how patients with cervical disc herniation and chronic neck pain fare after treatment with Absolute Gel, used in standard clinical practice.
-
Steroid Injections for Back and Neck Pain: What Works Best
This study tests different steroid injections and combinations to see what provides the best pain relief and function for adults with back or neck pain.
-
SCENAR therapy for chronic neck pain
This study tests whether repeating SCENAR therapy can reduce disability and pain for adults with long-standing non-specific neck pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.